CalciMedica, Inc. (CALC)
NASDAQ: CALC · Real-Time Price · USD
0.577
-0.014 (-2.30%)
At close: Apr 28, 2026, 4:00 PM EDT
0.572
-0.005 (-0.78%)
After-hours: Apr 28, 2026, 7:58 PM EDT
CalciMedica Stock Forecast
CALC's stock price has decreased by -61.57% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 1 analyst with a 12-month price forecast for CalciMedica stock has a target of 10, which predicts an increase of 1,634.61% from the current stock price of 0.58.
Analyst Consensus: Buy
* Price targets were last updated on Mar 5, 2026.
Analyst Ratings
The average analyst rating for CalciMedica stock from 2 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 0 | 0 | 1 | 1 |
| Hold | 0 | 0 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 1 | 1 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Oppenheimer | Oppenheimer | Buy Maintains $20 → $10 | Buy | Maintains | $20 → $10 | +1,634.61% | Mar 5, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Jan 29, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $16 | Strong Buy | Reiterates | $16 | +2,675.37% | May 15, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $16 | Strong Buy | Reiterates | $16 | +2,675.37% | Apr 1, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $16 | Strong Buy | Reiterates | $16 | +2,675.37% | Mar 4, 2025 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
6.80M
EPS This Year
-1.26
from -1.97
EPS Next Year
-2.20
from -1.26
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | n/a | 21.0M | |
| Avg | n/a | 6.8M | |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -1.02 | -0.90 | |
| Avg | -1.26 | -2.20 | |
| Low | -1.42 | -3.51 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.